To accurately gauge the impact of the National Cancer Act of 1971 at the half-century point, Abbe R. Gluck and Charles S. Fuchs decided to focus on more than the science of cancer.
NCI is temporarily reducing its paylines as the federal government is being funded at FY2021 levels via another continuing resolution, delaying the budgeting process for most federal agencies in the new fiscal year.
Congress has extended FY22 spending talks once again, leaving the proposed Advanced Research Projects Agency for Health (ARPA-H)—a key piece of President Joe Biden’s cancer agenda—in limbo.
God did not intend directors of NCI-designated cancer centers to last in their jobs forever.
Spotlight article Video: Nixon National Cancer Conference Kicks OffBy Richard Nixon Foundation | Dec. 8, 2021 On Dec. 23, 1971, in the East Room of the White House, describing it as something akin to a Christmas gift to the American people, President Richard Nixon signed the National Cancer Act of 1971. “We are here today […]
Every cancer center seeking to obtain (or keep) an NCI designation will soon have to present a plan for increasing the diversity of their faculty and workforce.
DEI Network founders: Let’s work together to increase diversity across all cancer centers in America
Christopher Li and Wendy Law, both of Fred Hutchinson Cancer Research Center, have a message for leaders of DEI programs in oncology.
Here is an update on the FDA effort to cull the backlog of what the agency has colorfully dubbed the “dangling indications” of cancer drugs: two indications taken off the market by sponsors; one facing an uncertain future.
A 1990 Nobel Prize in Physiology or Medicine awarded to E. Donnall Thomas for his discoveries in bone marrow transplantation has been put up for sale by his family.
Soon after starting work on a book about the role the NCI-designated cancer centers have played in the National Cancer Program, Skip Trump and Eric Rosenthal got in touch with John W. Yarbro.
